New Hyde Park, NY: The Parker Jewish Institute has launched bedside blood transfusions for residents and chronic-care patients, offering a safer, more comfortable alternative to hospital-based transfusions. Approved by the New York State Department of Health, this new service reduces avoidable hospital visits, supports early intervention and strengthens Parker’s commitment to delivering comprehensive, patient-centered care right on its campus.
By partnering with trusted provider, New York Blood Center/Blood Bank of Delmarva, Parker ensures that transfusions are administered at the bedside, with the highest standards of safety, clinical oversight and continuous clinical monitoring. Eligible residents and patients, including those receiving dialysis, can now access transfusions without the tension or risk often associated with hospital trips.
This offering is part of Parker’s growing continuum of integrated medical services, which include short term rehabilitation, long term care and on-site dialysis. Bedside transfusions complement these services by allowing timely care delivery, preventing complications and reducing unnecessary hospital admissions — all while keeping patients in a familiar and supportive environment.
“We are very proud to bring this level of care directly to our patients,” said Michael N. Rosenblut, President and CEO of Parker Jewish Institute. “By offering bedside transfusions, our nurses, physicians and dialysis specialists can intervene sooner and keep patients comfortable. This program enhances safety, supports better outcomes and aligns with our mission to deliver high-quality, dignified care where patients need it most.”
